The Feasibility of C-Reactive Protein Point-of-Care Testing to Reduce Overuse of Antibiotics in Children with Acute

Elvira Isaeva1, Azamat Akylbekov2, Joakim Bloch3

  • 1Allergology Department, National Centre of Maternity and Childhood Care (NCMCC), Bishkek, Kyrgyzstan.

Insights

In Kyrgyzstan, C-reactive protein (CRP) testing guided antibiotic use in children with acute respiratory tract infections (ARTI), significantly reducing antibiotic prescriptions. The pilot study proved feasible and safe, paving the way for a larger trial.

Area of Science:

  • Pediatric infectious diseases
  • Clinical microbiology
  • Public health interventions

Background:

  • High morbidity from acute respiratory tract infections (ARTI) in Kyrgyz children.
  • Inappropriate antibiotic prescribing by healthcare workers (HCW) due to various factors.
  • Need for point-of-care testing (POCT), like C-reactive protein (CRP), to guide antibiotic decisions.

Purpose of the Study:

  • To assess the feasibility of methods for a randomized controlled trial (NCT05195866) on CRP-guided antibiotic stewardship.
  • To evaluate the implementation of CRP POCT in primary care for children with ARTI.
  • To examine the safety and effectiveness of CRP-guided treatment in a pilot setting.

Main Methods:

  • Training HCWs in rural Kyrgyzstan on CRP POCT and result interpretation.
  • Randomly assigning children (6 months–12 years) with respiratory symptoms to CRP-guided or standard care.
  • Following up children for 14 days via telephone calls.

Main Results:

  • The CRP POCT and trial procedures were well-accepted by participants and HCWs.
  • Antibiotic use was significantly lower in the CRP-guided group compared to standard care.
  • No safety concerns were identified; children in both groups recovered similarly.

Conclusions:

  • CRP-guided antibiotic stewardship is feasible and safe for children with ARTI in primary care.
  • The pilot study provides satisfactory evidence for the effectiveness of CRP POCT in reducing antibiotic prescriptions.
  • Minor adjustments are needed for the main COORDINATE trial, particularly regarding participant follow-up data collection.
Abstract